SCHEMBL954228

SCHEMBL954228

Cc1nc2ccccn2c1C(N)=S

nearest known ligand 0.64

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.64
ALDH1A1 P00352 4/20 0.61
KDM4E B2RXH2 3/20 0.61
GAA P10253 2/20 0.61
MAPK1 P28482 1/20 0.56
NPSR1 Q6W5P4 1/20 0.55
HSD17B10 Q99714 1/20 0.55
NPC1 O15118 2/20 0.55
RAB9A P51151 2/20 0.55
TP53 P04637 1/20 0.55
SMN1; SMN2 Q16637 2/20 0.53
RXFP1 Q9HBX9 1/20 0.53
LMNA P02545 2/20 0.52
HTT P42858 2/20 0.52
MAPT P10636 2/20 0.52
MEN1 O00255 1/20 0.52
GLA P06280 1/20 0.51
POLB P06746 1/20 0.50
TDP1 Q9NUW8 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL954303 0.83 KMT2A (0.73) KMT2AALDH1A1KDM4EGAAMAPK1
SCHEMBL15747676 0.83 KMT2A (0.64) KMT2AALDH1A1KDM4EGAAMAPK1
SCHEMBL8315301 0.78 KMT2A (1.00) KMT2AALDH1A1KDM4EGAAMAPK1
SCHEMBL196599 0.78 KMT2A (1.00) KMT2AALDH1A1KDM4EGAAMAPK1
SCHEMBL954146 0.78 KMT2A (0.76) KMT2AALDH1A1KDM4EGAAMAPK1
SCHEMBL2937795 0.77 KMT2A (0.73) KMT2AALDH1A1KDM4EGAAMAPK1
SCHEMBL4343195 0.76 KDM4E (1.00) KMT2AALDH1A1KDM4EGAAMAPK1
SCHEMBL8312072 0.75 KMT2A (0.67) KMT2AALDH1A1KDM4EGAAMAPK1
Hydrochloric Acid SCHEMBL5887507 0.75 ALDH1A1 (0.68) KMT2AALDH1A1KDM4EGAAMAPK1
SCHEMBL15004608 0.74 KMT2A (0.61) KMT2AALDH1A1KDM4EGAAMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025242565-A1 AUTOPHAGY INDUCING COMPOUNDS AND USES THEREOF IN THE PREVENTION OR THERAPY OF DISEASES Samsara Therapeutics Inc. (US) 2025-11-27 WO disclosed
EP-4653432-A1 AUTOPHAGY INDUCING COMPOUNDS AND USES THEREOF IN THE PREVENTION OR THERAPY OF DISEASES Samsara Therapeutics Inc. (US) 2025-11-26 EP disclosed
US-9139589-B2 Heteroaryls and uses thereof MILLENNIUM PHARMACEUTICALS, INC. (US) 2015-09-22 US disclosed
US-9090601-B2 Thiazole derivatives MILLENNIUM PHARMACEUTICALS, INC. (US) 2015-07-28 US disclosed
EP-2391619-A1 HETEROARYLS AND THEIR USE AS PI3K INHIBITORS Millennium Pharmaceuticals, Inc. (US) 2011-12-07 EP disclosed
US-20110003807-A1 Thiazole derivatives MILLENNIUM PHARMACEUTICALS, INC. (US) 2011-01-06 US disclosed
US-20110003806-A1 Heteroaryls and uses thereof MILLENNIUM PHARMACEUTICALS, INC. (US) 2011-01-06 US disclosed
WO-2010090716-A1 HETEROARYLS AND THEIR USE AS PI3K INHIBITORS MILLENNIUM PHARMACEUTICALS, INC. (US) 2010-08-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110003807-A1 Thiazole derivatives MTOR, RICTOR, AKT2 KMT2A 2441/4885ALDH1A1 1687/4885KDM4E 1981/4885
US-20110003806-A1 Heteroaryls and uses thereof RICTOR, MTOR, AKT1S1 KMT2A 2459/4885ALDH1A1 728/4885KDM4E 2304/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.